StockpollyBeta
Get App
Popularity #3,564
ACOG · NASDAQ · Biotechnology

Alpha Cognition (ACOG)

Markets an oral Alzheimer’s treatment while developing related neurodegeneration programs.

$8.88
vs last close−0.07 (−0.81%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000323346
Cost of revenue000000111000
Gross profit000000212336
324222678101113
Research & development111111001112
113111577101011
Selling & marketing000000000000
General & administrative1131115700011
Other expenses000000000000
Operating income−3−2−4−2−2−2−4−6−5−8−8−8
−1−4−100−32−5412−1
Interest income000000000110
Interest expense000000000000
Other non-operating income141003−20000−1
Income before tax−3−6−5−2−2−6−2−10−1−7−6−9
Net income from continuing operations−3−6−5−2−2−6−2−10−1−7−6−9
Net income−3−6−5−2−2−6−2−10−1−7−6−9
EPS, basic−$0.84−$1.55−$0.75−$0.35−$0.31−$0.51−$0.13−$0.65−$0.08−$0.31−$0.30−$0.40
EPS, diluted−$0.84−$1.55−$0.75−$0.35−$0.31−$0.51−$0.13−$0.65−$0.08−$0.31−$0.32−$0.40
Weighted average shares, basic4466611161616222222
Weighted average shares, diluted4466611161616222222
EBITDA−3−6−5−2−2−6−2−6−5−8−8−6
Depreciation & amortization000000000000
EBIT−3−6−5−2−2−6−2−6−5−8−8−6